VALU

$36.39

Post-MarketAs of Mar 17, 8:00 PM UTC

Value Line, Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JPMBACGS

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$36.39
Potential Upside
37.9%
Whystock Fair Value$50.18
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorFinancial Services
IndustryFinancial Data & Stock Exchanges

Value Line, Inc. engages in the production and sale of investment periodicals and related publications. Its investment periodicals and related publications cover a range of investments, including stocks, mutual funds, exchange traded funds (ETFs), an...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$341.70M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.10
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.23
Div Yield
Strong income play. Yield provides a meaningful total return floor.
359.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
21.02%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.95

Recent News

Associated Press Finance
Mar 17, 2026

Value Line: Fiscal Q3 Earnings Snapshot

NEW YORK (AP) — Value Line Inc. VALU) on Tuesday reported profit of $5.9 million in its fiscal third quarter. On a per-share basis, the New York-based company said it had net income of 63 cents.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

The Zacks Analyst Blog JPMorgan, Johnson & Johnson, Applied Materials and Value Line

JPMorgan, Johnson & Johnson and Applied Materials stand out in new research reports, highlighting strong business momentum despite industry and macro headwinds.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 11, 2026

Top Research Reports for JPMorgan, Johnson & Johnson & Applied Materials

JPMorgan targets 9% NII growth, Johnson and Johnson leans on new drugs and MedTech strength, and Applied Materials rides a semiconductor rebound despite rising risks.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 9, 2026

Value Line (NASDAQ:VALU) shareholders have endured a 20% loss from investing in the stock three years ago

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Dec 24, 2025

The Zacks Analyst Blog Highlights Mastercard, GE Aerospace, Micron Technology and Value Line

Zacks' Analyst Blog spotlights Mastercard, GE Aerospace, Micron and Value Line, highlighting strong performance drivers and key risks shaping outlooks.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.